TITLE

Mid-potency topical corticosteroid for dermatoses

PUB. DATE
March 1994
SOURCE
Modern Medicine;Mar94, Vol. 62 Issue 3, p25
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports that the mid-potency topical corticosteroid prednicarbate emollient cream has been approved for relieving the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Application of the cream; Side-effects.
ACCESSION #
9607255804

 

Related Articles

  • Seeking a replacement for HRT. Hilton, Lusette // Dermatology Times;Mar2007, Vol. 28 Issue 3, p26 

    This article discusses benefits and harms of hormone replacement therapy (HRT), with specific reference to certain alternative therapy. In the wake of researches showing that women face higher risk for cancer and heart disease with HRT, dermatologists find it difficult to forward their arguments...

  • Hormonal treatment of acne vulgaris: an update. Elsaie, Mohamed L. // Clinical, Cosmetic & Investigational Dermatology;Sep2016, Vol. 9, p241 

    Acne vulgaris is a common skin condition associated with multiple factors. Although mostly presenting alone, it can likewise present with features of hyperandrogenism and hormonal discrepancies. Of note, hormonal therapies are indicated in severe, resistant-to-treatment cases and in those with...

  • Fluticasone Topical.  // AHFS Consumer Medication Information;Sep2020, p1 

    Fluticasone, a corticosteroid, is used to reduce inflammation and relieve itching, redness, dryness, and scaling associated with various skin disorders. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

  • New thinking on psoriasis. Young, Stephanie // Glamour;Apr93, Vol. 91 Issue 4, p48 

    Offers a look at psoriasis. Stress plays a major role in aggravating the condition for some people; Alcohol can set off psoriasis; Obesity and overeating may cause an outbreak; Better remedies for scalp psoriasis; New, more effective topical treatments; Details.

  • Cyclosporine for plaque-type psoriasis. Ellis, C.N.; Fradin, M.S. // New England Journal of Medicine;1/31/91, Vol. 324 Issue 5, p277 

    Reports the results of a 16-week, double-blind, dose-response trial in a single study center to determine the efficacy of three doses of cyclosporine in 85 patients with psoriasis. Background; Methods; Results; Conclusions.

  • The challenge of intracellular pathogens. Mahmoud, A.A.F. // New England Journal of Medicine;3/12/92, Vol. 326 Issue 11, p761 

    Editorial. Discusses the identification of several species and subspecies of leishmania. Studies that have examined the role of parasite surface molecules; Possible efficacy of allopurinol in the treatment of American cutaneous leishmaniasis; More.

  • Perifollicular pigmentation in bullous pemphigoid: A diagnostic sign. Kumaresan, M.; Srinivas, C. R. // Indian Dermatology Online Journal;2011, Vol. 2 Issue 1, p36 

    The article discusses the healing stage of bullous pemphigoid (BP), that shows the prominence of hair follicles appearing as tiny raised papules over raw areas followed by follicular pigmentation, as well as intense postinflammatory pigmentation.

  • Fact Box.  // Current Health 2;Oct2002, Vol. 29 Issue 2, SKIN SMARTS: A TEEN'S... p4 

    Focuses on the role of a dermatologist in treating a wide variety of medical, surgical and cosmetic problems. List of symptoms needing a dermatologist's attention; Importance of early treatment; Prevention of serious dermatological condition.

  • New warning about Accutane and birth defects. Willis, J. // FDA Consumer;Oct88, Vol. 22 Issue 8, p26 

    In the wake of new reports of birth defects in babies whose mothers took the acne drug Accutane, the US Food and Drug Administration (FDA) and the drug maker, Hoffmann La Roche, are using bolder warnings against using the drug during pregna ncy. Restrictions; Label warnings; Effects of Accutane.

  • Recent Developments in Receptor-Selective Retinoids. Nagpal, Sunil; Chandraratna, Roshantha A.S. // Current Pharmaceutical Design;Jun2000, Vol. 6 Issue 9, p919 

    Natural (all trans-retinoic acid, RA) and synthetic retinoids exhibit potent anti-proliferative, normalization of differentiation and anti-inflammatory activities which appear to account for their therapeutic effects in acne, psoriasis, photoaging, precancerous lesions and established cancers....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics